Different inactivating mutations of the mineralocorticoid receptor in fourteen families affected by type I pseudohypoaldosteronism

Journal of Clinical Endocrinology and Metabolism

Volumn 88, Issue 6, 2003, Pages 2508-2517

  Sartorato, Paola ^a,d   Lapeyraque, Anne Laure ^b   Armanini, Decio ^d   Kuhnle, Ursula ^e   Khaldi, Yasmina ^a   Salomon, Rémi ^c   Abadie, Véronique ^c   Di Battista, Eliana ^f   Naselli, Arturo ^f   Racine, Alain ^h   Bosio, Maurizio ⁱ   Caprio, Massimiliano ^j   Poulet Young, Véronique ^l   Chabrolle, Jean Pierre ^l   Niaudet, Patrick ^c   De Gennes, Christiane ^k   Lecornec, Marie Hélène ^a   Poisson, Elodie ^a   Fusco, Anna Maria ^g   Loli, Paola ^g   Lombès, Marc ^a   Zennaro, Maria Christina ^a   more..

^a INSERM   (France)

^b HÔPITAL ROBERT DEBRÉ   (France)

^c HÔPITAL NECKER ENFANTS MALADES   (France)

^d UNIVERSITY OF PADOVA   (Italy)

^e UNIVERSITY OF MUNICH   (Germany)

^f G GASLINI INSTITUTE   (Italy)

^g OSPEDALE NIGUARDA CA GRANDA   (Italy)

^h Centre Hospitalier Henri Mondor   (France)

ⁱ Centro Diagnostico Italiano   (Italy)

^j UNIVERSITY OF ROME TOR VERGATA   (Italy)

^k Orsay Hospital   (France)

^l LE HAVRE HOSPITAL   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; MINERALOCORTICOID RECEPTOR;

ANIMAL CELL; ARTICLE; AUTOSOMAL DOMINANT DISORDER; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE CLASSIFICATION; DNA BINDING; DRUG DOSE; FAILURE TO THRIVE; FAMILY; FEMALE; GENE INACTIVATION; GENE MUTATION; GENETIC STRAIN; HETEROZYGOSITY; HORMONE BINDING; HUMAN; LIGAND BINDING; MALE; MISSENSE MUTATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PSEUDOHYPOALDOSTERONISM; SALT LOSING NEPHRITIS; TRANSACTIVATION; WILD TYPE;

ANIMALIA;

EID: 0037968583     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2002-021932     Document Type: Article

References (38)

1. Verrey F, Pearce D, Pfeiffer R, Spindler B, Mastroberardino L, Summa V, Zecevic M 2000 Pleiotropic action of aldosterone in epithelia mediated by transcription and post-transcription mechanisms. Kidney Int 57:1277-1282
2. Mangelsdorf DJ, Thummel C, Beato M, Herrlich P, Schütz G, Umesono K, Blumberg B, Kastner P, Mark M, Chambon P, Evans RN 1995 The nuclear receptor superfamily: the second decade. Cell 83:835-839
3. Arriza JL, Weinberger C, Cerelli G, Glaser TM, Handelin BL, Housman DE, Evans RM 1987 Cloning of human mineralocorticoid receptor complementary DNA: structural and functional kinship with the glucocorticoid receptor. Science 237:268-275
4. Aranda A, Pascual A 2001 Nuclear hormone receptors and gene expression. Physiol Rev 81:1269-304
5. Boulkroun S, Fay M, Zennaro MC, Escoubet B, Jalsser F, Blot-Chabaud M, Farman N, Courtois-Coutry N 2002 Characterization of rat NDRG2 (N-Myc downstream regulated gene 2), a novel early mineralocorticoid-specific induced gene. J Biol Chem 277:31506-21515
6. Farman N, Rafestin-Oblin ME 2001 Multiple aspects of mineralocorticoid selectivity. Am J Physiol Renal Physiol 280:F181-F192
7. Young M, Funder JW 2000 Aldosterone and the heart. Trends Endocrinol Metab 11:224-226
8. Gomez-Sanchez EP, Venkataraman MT, Thwaites D 1990 ICV infusion of corticosterone antagonizes ICV-aldosterone hypertension. Am J Physiol 258:E649-E653
9. Pitt B, Zannad F, Remme W, Cody R, Castaigne A, Perez A, Palensky J, Wittes J 1999 The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med 341:709-717
10. Rondinone CM, Robbard D, Baker ME 1993 Aldosterone stimulates differentiation of mouse 3T3-L1 cells into adipocytes. Endocrinology 132:2421-2426
11. Zennaro MC, Le Menuet D, Viengchareun S, Walker F, Ricquier D, Lombes M 1998 Hibernoma development in transgenic mice identifies brown adipose tissue as a novel target of aldosterone action. J Clin Invest 101:1254-1260
12. Penfornis P, Viengchareun S, Le Menuet D, Cluzeaud F, Zennaro MC, Lombes M 2000 The mineralocorticoid receptor mediates aldosterone-induced differentiation of T37i cells into brown adipocytes. Am J Physiol Endocrinol Metab 279:E386-E394
13. Viengchareun S, Penfornis P, Zennaro MC, Lombes M 2001 Mineralocorticoid and glucocorticoid receptors inhibit UCP expression and function in brown adipocytes. Am J Physiol Endocrinol Metab 280:E640-E649
14. Zennaro M-C, Keightley MC, Kotelevtsev Y, Conway G, Soubrier F, Fuller PJ 1995 Human mineralocorticoid receptor genomic structure and identification of expressed isoforms. J Biol Chem 270:21016-21020
15. Zennaro M-C, Farman N, Bonvalet J-P, Lombes M 1997 Tissue-specific expression of α and β messenger ribonucleic acid isoforms of the human mineralocorticoid receptor in normal and pathological states. J Clin Endocrinol Metab 82:1345-1352
16. Zennaro M-C, Le Menuet D, Lombès M 1996 Characterization of the human mineralocorticoid receptor gene 5′-regulatory region: evidence for differential hormonal regulation of two alternative promoters via non-classical mechanisms. Mol Endocrinol 10:1549-1560
17. Le Menuet D, Viengchareun S, Penfornis P, Walker F, Zennaro MC, Lombes M 2000 Targeted oncogenesis reveals a distinct tissue-specific utilization of alternative promoters of the human mineralocorticoid receptor gene in transgenic mice. J Biol Chem 275:7878-7886
18. Bloem LJ, Guo C, Pratt JH 1995 Identification of a splice variant of the rat and human mineralocorticoid receptor genes. J Steroid Biochem Mol Biol 55:159-162
19. Zhou MY, Gomez-Sanchez CE, Gomez-Sanchez EP 2000 An alternatively spliced rat mineralocorticoid receptor mRNA causing truncation of the steroid binding domain. Mol Cell Endocrinol 159:125-131
20. Zennaro MC, Souque A, Viengchareun S, Poisson E, Lombes M 2001 A new human MR splice variant is a ligand-independent transactivator modulating corticosteroid action. Mol Endocrinol 15:1586-1598
21. Zennaro M-C, Armanini D, Mantero F 1999 Mineralocorticoid resistance. Top Endocrinol 12:2-6
22. Kuhnle U, Nielsen MD, Tietze HU, Schroeter CH, Schlamp D, Bosson D, Knorr D, Armanini D 1990 Pseudohypoaldosteronism in eight families: different forms of inheritance are evidence for various genetic defects. J Clin Endocrinol Metab 638-641
23. Hanukoglu A 1991 Type I pseudohypoaldosteronism includes two clinically and genetically distinct entities with either renal or multiple target organ defects. J Clin Endocrinol Metab 73:936-944
24. Geller DS, Rodriguez-Soriano J, Vallo Boado A, Schifter S, Bayer M, Chang SS, Lifton RP 1998 Mutations in the mineralocorticoid receptor gene cause autosomal dominant pseudohypoaldosteronism type I. Nat Genet 19:279-281
25. Viemann M, Peter M, Lopez-Siguero JP, Simic-Schleicher G, Sippell WG 2001 Evidence for genetic heterogeneity of pseudohypoaldosteronism type 1: identification of a novel mutation in the human mineralocorticoid receptor in one sporadic case and no mutations in two autosomal dominant kindreds. J Clin Endocrinol Metab 86:2056-2059
26. Tajima T, Kitagawa H, Yokoya S, Tachibana K, Adachi M, Nakae J, Suwa S, Katoh S, Fujieda K 2000 A novel missense mutation of mineralocorticoid receptor gene in one Japanese family with a renal form of pseudohypoaldosteronism type 1. J Clin Endocrinol Metab 85:4690-4694
27. Massaad C, Houard N, Lombes M, Barouki R 1999 Modulation of human mineralocorticoid receptor function by protein kinase A. Mol Endocrinol 13:57-65
28. Vandewalle A, Lelongt B, Geniteau-Legendre M, Baudouin B, Antoine M, Estrade S, Chatelet F, Verroust P, Cassingena R, Ronco P 1989 Maintenance of proximal and distal cell functions in SV40-transformed tubular cell lines derived from rabbit kidney cortex. J Cell Physiol 141:203-221
29. Claire M, Rafestin-Oblin ME, Michaud A, Corvol P, Venot A, Roth-Meyer C, Boisvieux JF, Mallet A 1978 Statistical test of models and computerised parameter estimation for aldosterone binding in rat kidney. FEBS Lett 88:295-299
30. Fagart J, Wurtz JM, Souque A, Hellal-Levy C, Moras D, Rafestin-Oblin ME 1998 Antagonism in the human mineralocorticoid receptor. EMBO J 17:3317-3325
31. Chavez B, Mendez JP, Ulloa-Aguirre A, Larrea F, Vilchis F 2001 Eight novel mutations of the androgen receptor gene in patients with androgen insensitivity syndrome. J Hum Genet 46:560-565
32. Black BE, Holaska JM, Rastinejad F, Paschal BM 2001 DNA binding domains in diverse nuclear receptors function as nuclear export signals. Curr Biol 11:1749-1758
33. Couette B, Jalaguier S, Hellal-Levy C, Lupo B, Fagart J, Auzou G, Rafestin-Oblin ME 1998 Folding requirements of the ligand-binding domain of the human mineralocorticoid receptor. Mol Endocrinol 12:855-863
34. Yen PM, Chin WW 1994 Molecular mechanisms of dominant negative activity by nuclear hormone receptors. Mol Endocrinol 8:1450-1454
35. Liu HX, Cartegni L, Zhang MQ, Krainer AR 2001 A mechanism for exon skipping caused by nonsense or missense mutations in BRCA1 and other genes. Nat Genet 27:55-58
36. Krawczak M, Reiss J, Cooper DN 1992 The mutational spectrum of single base-pair substitutions in mRNA splice junctions of human genes: causes and consequences. Hum Genet 90:41-54
37. Arai K, Tsigos C, Suzuki Y, Listwak S, Zachman K, Zangeneh F, Rapaport R, Chanoine J-P, Chrousos GP 1995 No apparent mineralocorticoid receptor defect in a series of sporadic cases of pseudohypoaldosteronism. J Clin Endocrinol Metab 80:814-817
38. Ludwig M, Bolkenius U, Wickert L, Bidlingmaier F 1998 Common polymorphisms in genes encoding the human mineralocorticoid receptor and the human amiloride-sensitive sodium channel. J Steroid Biochem Mol Biol 64:227-230